Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-11-21FDA Approved: INDOMETHACIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves a supplemental application for Indomethacin from Amneal Pharmaceuticals LLC (ANDA 091549), authorizing a supplemental change to…
-
FDA label_change · 2024-11-21FDA Approved: SULINDAC — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental labeling change for sulindac from Actavis Pharma, updating the product labeling under the ANDA. This reflects ad…
-
FDA approval · 2024-11-21FDA Approved: CELEBREX — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Celebrex (celecoxib) filed by Viatris Specialty LLC. The approval covers changes requested i…
-
FDA approval · 2024-11-21FDA Approved: MELOXICAM — Supplemental Application (AiPing Pharmaceutical, Inc)
FDA approved a supplemental application for meloxicam from AiPing Pharmaceutical, Inc. The approval pertained to updating the labeling under…
-
FDA approval · 2024-11-21FDA Approved: MELOXICAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for meloxicam, confirming regulatory clearance for the product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo [Phase 3]
Phase 3 clinical trial evaluating the effectiveness of Jitongning Tablets versus placebo in adults with Ankylosing Spondylitis; recruitment …
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Psychosocial and Functional Factors in AxSpA
The update reports on a completed clinical trial studying psychosocial and functional factors in axial spondyloarthritis (ankylosing spondyl…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis [Phase 2]
This Phase 2 trial update reports long-term safety and efficacy results for bimekizumab in adults with ankylosing spondylitis; the study has…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Efficacy of Pain Neuroscience Education and Physiotherapy in Patients Diagnosed with Spondyloarthritis [NA]
A completed clinical trial evaluated the effects of pain neuroscience education and physiotherapy for spondyloarthropathies, including ankyl…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Effect of IL17 Inhibitor in Comparison With Anti-TNF in Patients With Ankylosing Spondylitis
This clinical trial update describes a study comparing an interleukin-17 inhibitor with an anti-TNF agent in patients with ankylosing spondy…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: The Effect of Mobile Application on Subcutaneous Anti-TNF Drug Administration:Ankylosing Spondylitis Patients [NA]
A clinical trial investigating a mobile application to assist subcutaneous anti-TNF administration in ankylosing spondylitis has completed.
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Cardiovascular Disease Risk Factors and Healthy Lifestyle Behaviours in Patients with Ankylosing Spondylitis
A recruiting study evaluating cardiovascular disease risk factors and the impact of healthy lifestyle behaviours in patients with Ankylosing…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS) [Phase 2]
This entry provides a trial update for a Phase 2 study of the investigational drug 608 in Ankylosing Spondylitis. The current status of the …
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Impact of Air Pollution on the Course of Inflammatory Rheumatism [NA]
A clinical trial investigating the impact of air pollution on the course of inflammatory rheumatic diseases, including rheumatoid arthritis,…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis [Phase 3]
Phase 3 trial assessing efficacy and safety of bimekizumab in active ankylosing spondylitis has completed with results posted on 2024-10-10.
-
FDA approval · 2024-09-27FDA Approved: CELECOXIB — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Celecoxib from Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
This clinical trial update notes that the study evaluating gynecological follow-up in patients with autoimmune diseases and inflammatory rhe…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Osteosarcopenia in Axial Spondyloarthritis
This ClinicalTrials.gov entry reports that Ankara University is recruiting participants for a study on osteosarcopenia in axial spondyloarth…
-
FDA approval · 2024-08-26FDA Approved: ADALIMUMAB-RYVK — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for ADALIMUMAB-RYVK, a biosimilar to adalimumab, submitted by Quallent Pharmaceuticals Health LL…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Inturlekin L33 in Ankylosing Spondylities Patients and Its Relation to Subclinical Atherosclerosis
A clinical trial update notes a planned study of Inturlekin L33 in Ankylosing Spondylitis to evaluate its relation to subclinical atheroscle…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With Golimumab
A completed clinical trial evaluated clinical and radiological manifestations of Coxitis in patients with Ankylosing Spondylitis treated wit…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy [NA]
Clinical trial update on integrating remote monitoring into chronic immunosuppressive therapy for rheumatoid arthritis, psoriatic arthritis,…
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. [Phase 2]
This document reports the completion of a Phase 2 trial evaluating the efficacy and safety of VC005 tablets in subjects with active ankylosi…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes [Phase 3]
A Phase 3 trial evaluating continuous non-steroidal anti-inflammatory drug therapy in ankylosing spondylitis patients on anti-TNF therapy to…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)
An active pharmacovigilance study is being conducted to monitor the safety of Rinvoq (upadacitinib) in inflammatory diseases. Recruitment fo…